Cvs Pharmacy #00043 | |
474 Washington St, Weymouth, Massachusetts 02188 | |
(781) 335-0404 |
Name | Cvs Pharmacy #00043 |
---|---|
Organization Name | Cvs Pharmacy Inc |
Location | 474 Washington St, Weymouth, Massachusetts 02188 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (781) 335-0404 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Men with breast cancer are more likely to die than their female counterparts, across all stages of disease, with the disparity persisting even when clinical characteristics, such as cancer types, treatment and access to care are considered, according to a study by Vanderbilt researchers published in JAMA Oncology.
Almost 100,000 terminally ill people in the UK do not get proper care, according to a Government review which concluded that a new funding system would save millions of pounds and better serve individuals.
On Wednesday 14 October, WHO will launch new guidance: Ethics & vector-borne diseases. The guidance document is a culmination of more than three years of work and will be a valuable new tool to support global efforts to prevent and control vector-borne diseases (VBDs).
As the world transitions from pandemic lockdowns, pediatric sleep experts have found some pluses of working from home, including more sleep for babies and less daytime drowsiness for parents.
King Pharmaceuticals®, Inc. and Pain Therapeutics®, Inc. today announced that King has resubmitted a New Drug Application for REMOXY® to the U.S. Food and Drug Administration in response to a Complete Response letter received by Pain Therapeutics in December 2008.
› Verified 6 days ago
NPI Number | 1043319494 |
Organization Name | CVS PHARMACY INC |
Doing Business As | CVS PHARMACY #00043 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 474 Washington St, Weymouth, MA 02188 |
Phone Number | 781-337-4516 |
News Archive
Men with breast cancer are more likely to die than their female counterparts, across all stages of disease, with the disparity persisting even when clinical characteristics, such as cancer types, treatment and access to care are considered, according to a study by Vanderbilt researchers published in JAMA Oncology.
Almost 100,000 terminally ill people in the UK do not get proper care, according to a Government review which concluded that a new funding system would save millions of pounds and better serve individuals.
On Wednesday 14 October, WHO will launch new guidance: Ethics & vector-borne diseases. The guidance document is a culmination of more than three years of work and will be a valuable new tool to support global efforts to prevent and control vector-borne diseases (VBDs).
As the world transitions from pandemic lockdowns, pediatric sleep experts have found some pluses of working from home, including more sleep for babies and less daytime drowsiness for parents.
King Pharmaceuticals®, Inc. and Pain Therapeutics®, Inc. today announced that King has resubmitted a New Drug Application for REMOXY® to the U.S. Food and Drug Administration in response to a Complete Response letter received by Pain Therapeutics in December 2008.
› Verified 6 days ago
News Archive
Men with breast cancer are more likely to die than their female counterparts, across all stages of disease, with the disparity persisting even when clinical characteristics, such as cancer types, treatment and access to care are considered, according to a study by Vanderbilt researchers published in JAMA Oncology.
Almost 100,000 terminally ill people in the UK do not get proper care, according to a Government review which concluded that a new funding system would save millions of pounds and better serve individuals.
On Wednesday 14 October, WHO will launch new guidance: Ethics & vector-borne diseases. The guidance document is a culmination of more than three years of work and will be a valuable new tool to support global efforts to prevent and control vector-borne diseases (VBDs).
As the world transitions from pandemic lockdowns, pediatric sleep experts have found some pluses of working from home, including more sleep for babies and less daytime drowsiness for parents.
King Pharmaceuticals®, Inc. and Pain Therapeutics®, Inc. today announced that King has resubmitted a New Drug Application for REMOXY® to the U.S. Food and Drug Administration in response to a Complete Response letter received by Pain Therapeutics in December 2008.
› Verified 6 days ago
Cvs Pharmacy #01853 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 737 Bridge St, Weymouth, Massachusetts 02191 Phone: (781) 335-3331 | |
Cvs Pharmacy #00043 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 474 Washington St, Weymouth, Massachusetts 02188 Phone: (781) 335-0404 | |
Cvs Pharmacy #02600 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1515 Commercial St, Weymouth, Massachusetts 02189 Phone: (781) 340-1124 | |
Walgreens #6470 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 750 Washington St, Weymouth, Massachusetts 02188 Phone: (781) 331-5301 | |
Wal-mart Pharmacy 10-3200 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 740 Middle St, Weymouth, Massachusetts 02188 Phone: (781) 331-0588 |